In a recent article Naturally Splendid (TSXV:NSP) CEO and Director Craig Goodwin highlighted how the company is building a portfolio of high quality hemp and plant-based products.
As quoted in the article:

Naturally Splendid has a solid business strategy. We strive to be cash flow positive with our conventional line of natural products through exporting and our retail lines. We plan on building these revenue streams while we pursue the ‘blue sky’ opportunities associated with our omega extraction and formulation technologies and products. We are also well positioned to capitalize on the evolving cannabinoid markets in North America in particular, but also globally as the regulations become more ‘cannabinoid friendly’. We also have majority ownership of a 12,000 square foot processing facility in Saskatoon, Saskatchewan that we can utilize for our own extraction and formulation of plant based ingredients and products such as HempOmega™. This facility can potentially be converted to perform cannabinoid extraction and formulation as the regulatory landscape evolves to allow for such procedures in Canada.
We have made significant progress exporting to South Korea. We initially anticipated exporting 100 tons of shelled hemp seed hearts to South Korea for all of 2016. Since initiating this exporting business in February 2016, we have shipped almost 400 tons of shelled hemp seed hearts for a value approaching $4M CDN.
We are now estimating that we may export upwards of 1,000 tons of shelled hemp seed hearts to South Korea in 2016. Additionally, we will begin to introduce additional products to the South Korean market including HempOmega™.
Now that there we are nearing a cash flow positive position, we can begin to focus more efforts to securing clients and purchase orders for our HempOmega™. With a cash flow positive company, we can also begin to revisit the cannabinoid opportunities evolving in the United States. It seems Naturally Splendid is firing on all cylinders, let’s put this in perspective and talk comparables within your sector.
I believe that most of the ‘heavy lifting’ is done. We have assembled a strong professional team, launched 3 retail brands, secured advanced technologies in the areas on plant based bio-ingredients including omega extraction and formulation, as well as secured significant cannabinoid technologies. We have also bought a majority interest in a processing facility with a replacement cost of $30M Canadian. We have launched an export division and our top line sales have already surpassed all of 2015…and it looks like quarters 2, 3 and 4 will be stronger than Q1.
In short, the Company is much further developed than last year when we traded as high as $1.04 per share. I do believe the future is very bright for Naturally Splendid and its shareholders.


Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less